Key Insights

Highlights

Success Rate

33% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 85/100

Termination Rate

18.2%

2 terminated out of 11 trials

Success Rate

33.3%

-53.2% vs benchmark

Late-Stage Pipeline

9%

1 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

33% success

Data Visualizations

Phase Distribution

11Total
Not Applicable (6)
P 2 (4)
P 3 (1)

Trial Status

Recruiting5
Not Yet Recruiting3
Terminated2
Completed1

Trial Success Rate

33.3%

Benchmark: 86.5%

Based on 1 completed trials

Clinical Trials (11)

Research Network

Activity Timeline